The admission by AstraZeneca that their COVID-19 vaccine can cause rare but severe blood clotting disorders has sent shockwaves through the medical community and raised serious questions about the safety of the vaccine. However, the European Medicines Agency (EMA) has taken a controversial stance amidst this scandal, which has further fueled public outrage and suspicion. Despite being aware of reports of blood clot complications associated with the AstraZeneca vaccine, the EMA has stated that "no link between the vaccine and blood clot complications was found" and continues to recommend the vaccine, arguing that "the benefits outweigh the risks." This statement has been met with fierce criticism, as many see it as a deceptive attempt to downplay the potential dangers of the vaccine. Critics argue that the EMA's position is essentially saying, "we don't know if it's relevant or not, you can just use it." This ambiguous stance does little to reas...